Literature DB >> 21866074

Vitreous inflammatory factors and serous macular detachment in branch retinal vein occlusion.

Hidetaka Noma1, Hideharu Funatsu, Tatsuya Mimura, Maria Tatsugawa, Katsunori Shimada, Shuichiro Eguchi.   

Abstract

PURPOSE: To investigate whether vascular endothelial growth factor, soluble intercellular adhesion molecule-1 (sICAM-1), and pigment epithelium-derived factor are associated with serous retinal detachment (SRD) secondary to branch retinal vein occlusion.
METHODS: The subjects were 44 branch retinal vein occlusion patients with macular edema and 16 controls. Patients were divided into 2 groups by optical coherence tomography findings, that is, 18 patients with SRD and 26 with cystoid macular edema. The area of capillary nonperfusion was measured with fluorescein angiography and Scion Image software. Vitreous fluid samples obtained during pars plana vitrectomy were examined by enzyme-linked immunosorbent assay.
RESULTS: The incidence of major branch retinal vein occlusion was significantly higher in SRD patients (17/18, 94%) than in cystoid macular edema patients (15/26, 58%, P = 0.007), while the nonperfused retinal area was significantly larger in SRD patients (P = 0.006). Vitreous fluid levels of vascular endothelial growth factor and soluble intercellular adhesion molecule-1 (sICAM-1) showed a significant increase across the 3 groups (control group, cystoid macular edema group, and SRD group) (P trend < 0.001 and P trend < 0.001, respectively), while the pigment epithelium-derived factor level showed a significant decrease across the 3 groups (P trend < 0.001).
CONCLUSION: An excessive increase of vascular permeability secondary to upregulation of vascular endothelial growth factor and soluble intercellular adhesion molecule-1 (sICAM-1) along with downregulation of pigment epithelium-derived factor may contribute to the development of SRD in BRVO patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21866074     DOI: 10.1097/IAE.0b013e31821801de

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

Review 1.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

2.  Choroidal thickening in retinal vein occlusion patients with serous retinal detachment.

Authors:  Lulu Chen; Mingzhen Yuan; Lu Sun; Youxin Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-18       Impact factor: 3.117

3.  Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Katsunori Shimada
Journal:  BMC Ophthalmol       Date:  2012-08-09       Impact factor: 2.209

4.  Inflammation in retinal vein occlusion.

Authors:  Avnish Deobhakta; Louis K Chang
Journal:  Int J Inflam       Date:  2013-04-03

5.  Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion.

Authors:  Emine Dogan; Ozkan Sever; Burcin Köklü Çakır; Erkan Celik
Journal:  Clin Ophthalmol       Date:  2018-08-17

6.  Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory Therapies.

Authors:  Xuefei Ding; Yijun Hu; Honghua Yu; Qiuming Li
Journal:  Drug Des Devel Ther       Date:  2022-03-15       Impact factor: 4.162

Review 7.  A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics.

Authors:  Bingjie Wang; Xiao Zhang; Huan Chen; Adrian Koh; Chan Zhao; Youxin Chen
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

8.  Prevalence of Serous Macular Detachment in Recurrent Macular Edema Secondary to Retinal Vein Occlusion.

Authors:  Mehmet Ali Şekeroğlu; Fatma Büşra Taşkale; Sibel Doğuizi; Pelin Yılmazbaş
Journal:  Turk J Ophthalmol       Date:  2022-08-25

9.  Comparison of Ranibizumab Treatment Response of Superior and Inferior Temporal Branch Retinal Vein Occlusion: A Year Follow-Up.

Authors:  Esra Turkseven Kumral; Nursal Melda Yenerel; Nimet Yesim Ercalik; Levent Karabas
Journal:  Beyoglu Eye J       Date:  2022-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.